Tempus AI (NASDAQ:TEM) Trading Up 5% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price was up 5% during mid-day trading on Monday . The company traded as high as $68.95 and last traded at $65.70. Approximately 158,119 shares traded hands during trading, a decline of 87% from the average daily volume of 1,183,667 shares. The stock had previously closed at $62.59.

Wall Street Analysts Forecast Growth

Several research firms have commented on TEM. Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and lifted their price target for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Needham & Company LLC reiterated a “buy” rating and set a $47.00 price target on shares of Tempus AI in a research note on Wednesday, August 7th. Loop Capital lifted their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Finally, Piper Sandler restated a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $54.22.

Tempus AI Trading Up 2.3 %

The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The business has a fifty day moving average price of $53.15.

Hedge Funds Weigh In On Tempus AI

Large investors have recently modified their holdings of the business. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI in the 3rd quarter worth approximately $30,000. Sandia Investment Management LP purchased a new stake in Tempus AI during the second quarter worth $136,000. Vestor Capital LLC acquired a new stake in Tempus AI in the third quarter valued at $153,000. Stifel Financial Corp purchased a new position in shares of Tempus AI in the third quarter valued at $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in shares of Tempus AI in the third quarter valued at $258,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.